Antidepressants
- *
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: G. Sivagnanam
Copyright: © 2012 The Author(s). This is an open access article.
Published: Jan 1, 2012
- DOI
- Not available yet
Abstract
In the present day context, antidepressants are most commonly prescribed in depression and generalized anxiety disorders, not to mention a host of other neuropsychiatric and off-label indications. Thus, the magnitude of antidepressant prescriptions would equate in terms of billions of dollars each year. Apart from the depression caused on health economy, the emerging reports of serious adverse effects caused by the more commonly used group - SSRIs is by itself depressing
Keywords
Subject
Recommended articles
- New(s): Are these terms new(s)!?
G. Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Antibiotics with a curse of cardiovascular risk
G Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Acetaminophen associated with risk of hearing loss: A safety alert
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- A new drug belonging to a novel class of drugs for type 2 diabetes
Sivagnanam G · Journal of Pharmacology and Pharmacotherapeutics
- The enema of your enemy is your friend
· Journal of Pharmacology and Pharmacotherapeutics
- Baldness, a new marker for coronary heart disease risk
Sivagnanam G · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026